Idexx Laboratories (IDXX) stock

Pet tests , market cap $53B

Tests and equipment for pets and livestock

Worth $53B

$676.04

+0.79%

As of 8:42 AM ET pre-market, delayed 15+ min · Live for Pro members

Quality Score

Average

In its industry

#18of 90

Pharma

Checks firing

4of 14

Trending down

From 52-week high

-12.2%

under its best in a year

IDXX's Quality Score rose 1 point on Mon, Nov 9, to 10.

See IDXX's 14 chart checksSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is IDXX up?

Up 22% on Nov 2, and still 23% over its Oct 30 close.

“Increases 2026 revenue guidance to $4,741 million - $4,767 million, up $32 million at midpoint, reflecting strong CAG Diagnostics recurring revenue performance.”

Idexx Laboratories' Nov 2 release said

Sources: Price history, Nov 2, 2026; Company release, Nov 2, 2026

1 more reason, free with an account →3 more reasons why IDXX rose on Nov 2, from its filings, with the other side, the company's words, the timeline, and its peers, for Pro members.

Why IDXX still lags the market over five years

Up 7% over the five years to Nov 6 while the S&P 500 rose 68%; up 22% on Nov 2.

1 reason, from its filings, with the timeline, for Pro members.

Key facts on IDXX

Key facts on IDXX
The company	Sales up 12% on the year
Latest filing	8-K, Nov 2 Reported its quarterly results

1 more reason behind IDXX's 10, free with an account →4 more reasons behind IDXX's 10, for Pro members.

IDXX in the news

Mon Nov 2IDEXX Laboratories Announces Third Quarter Results SEC filing 6:30 AM ET · Company newsroom and 5 more IDXX closed +21.8% that day.

IDXX catalysts

Coming up

After its last 4 reports it closed +5.2% on average, higher 2 of 4 times.

30 past catalysts since 2018, with sizes and sources, for Pro members.

Why IDXX scores 10

Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. IDXX scores 10 today, against a median of 5.5 over its last 20 recorded sessions.

+4Chart checks 4 of 14 firing right now, one point each
+3News guidance raised, earnings beat

Long-term trend adds
Size adds
Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Insider trades subtracts

No effect today: Run-up, Dilution, Volatility, Cash flow, and Persistence.

What every line is worth, and the reason behind it, on IDXX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:42 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when IDXX's Quality Score turns up

A free account. No card.

How IDXX ranks in Pharma

IDXX is #18 of 90 by Quality Score.

How IDXX ranks in Pharma
Rank	Stock	Checks	Quality Score
1	ABBVAbbVie	8/14	24
2	LLYEli Lilly	5/14	18
3	CRONCronos	5/14	18
	GSKGSK		Open for its score
	HROWHarrow		Open for its score
	INSMInsmed		Open for its score
	INVAInnoviva		Open for its score
18	IDXXIdexx Laboratories	4/14	10

When does IDXX report earnings, and what happens after?

Expected to report Mon Feb 1, before the open (in 84 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What IDXX reported on Nov 2, 2026

The quarter

Sales of $1.2B, 10% more than a year ago; a profit of $4.01 a share, from $3.40.

“Increases 2026 revenue guidance to $4,741 million - $4,767 million, up $32 million at midpoint, reflecting strong CAG Diagnostics recurring revenue performance.”

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q3 2026	Q2 2026	Q3 2025
By product
Productup 10%	$723M60%	$719M59%	$656M59%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 2)

9 more lines, for Pro members.

The outlook

The outlook the company gave, by period
Measure	Figure
Full year 2026
Revenue	$4.741B to $4.767Braised

Figures as filed (SEC filing, Nov 2)

5 more outlook lines, for Pro members.

The numbers

Market value: $53B; today
Sales: $4.7B; up 11.9% on the year
Free cash flow: $1.3B; last 12 months

Sales grew 9.7% a year over 5 years, fiscal 2020 to 2025.

Its share count fell 1.3% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on IDXX: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-0.0%+3.6%+21.9%

May 5Aug 4Nov 2

Reported	When	Gap	Reaction	5 days
Nov 2, 2026Before open	Before open	+13.4%	+21.9%	+22.6%
Aug 4, 2026Before open	Before open	+6.1%	+3.6%	+4.9%
May 5, 2026Before open	Before open	+1.1%	-0.0%	-5.5%

IDXX closed higher after 2 of its last 4 reports.

All 4 reports, and IDXX's Quality Score going into each

IDXX sales and profit by year

Sales and profit by year

Sales grew every year from 2018 to 2025, to $4.3B. It made a profit in each of the eight years.

IDXX has 4 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on IDXX, and all 14 on every stock.Get in free →

IDXX RSI on Nov 6: 71.0, above its 50-day and 200-day averages

Not scored

RSI 71.0, MACD above signal, above both averages. Not scored.13 readings

The deep dive on IDXX

What it does and how it makes money5 findingsServices made up 41% of its revenue in fiscal 2025 ($1.76B of $4.30B), against 42% in fiscal 2024; product sales 59%.SEC filing · Feb 20, 2026"In 2018, a lawsuit was filed against us involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement." (10-K for fiscal 2025)SEC filing · Feb 20, 2026
Where it stands3 findingsFor Pro members3 findings on where IDXX stands: its cash, debt, and share count, for Pro members
What changed in its filings1 finding"In 2018, a lawsuit was filed against us involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement." (10-K for fiscal 2025)SEC filing · Feb 20, 2026
Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades IDXX, for Pro members

10 more findings on IDXX, each with its source, for Pro members.

IDXX insider trades

5 insiders sold $28.6M across 22 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellSharon E. Underberg$4.4MEVP, GC & Corporate Secretaryat $688.25 on Nov 4, filed Nov 5

SellSharon E. UnderbergEVP, GC & Corporate Secretary$4.4Mat $688.25 on Nov 4, filed Nov 5

All 22 insider filings on IDXX from the last six months, for Pro members.

All IDXX insider trades

IDXX trades by Congress and the executive branch

19 trades disclosed in the last six months. The newest:

SellDonald Trump$50K to $100KPresident (R)traded Aug 21, disclosed Oct 8(48 days later)

SellDonald TrumpPresident (R)$50K to $100Ktraded Aug 21, disclosed Oct 8(48 days later)

All 19 trades on IDXX disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

IDXX's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Jonathan Jay MazelskyExecutive Chair of the Board · 26 trades
Andrew EmersonEVP, CFO and Treasurer · no trades on file
George FennellExecutive Vice President · 8 trades
Michael G. EricksonExecutive Vice President · 6 trades
Michael LaneExecutive Vice President · 3 trades
Sharon E. UnderbergEVP, GC & Corporate Secretary · 3 trades
Nimrata HuntExecutive Vice President · 2 trades
Martin Alexander SmithExecutive Vice President · no trades on file

8 more officers and directors file at IDXX.

See insider trades by person

Which ETFs hold IDXX?

In ETFs: IDXX is 0.3% of SPMO, 0.3% of QQQI, and 0.3% of QQQ, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.

About Idexx Laboratories

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

11,000 employeesWestbrook, MEidexx.com

What Idexx Laboratories says it competes with

“We compete with many companies ranging from large human and animal health pharmaceutical and medical diagnostics companies to small businesses focused on animal health.”

From its annual report, SEC filing · Feb 20, 2026

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on IDXX and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move IDXX's score: 6 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 7Ro Khanna bought IDXX$1K to $15K, disclosed Oct 7

Alerts are optional.

See IDXX's 14 chart checks

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 9, 2026: IDXX's Quality Score is 10 (Average), #18 of 90 in Pharma. Insiders sold $28.6M in the last 6 months (Form 4).

What does IDXX's Quality Score say?

IDXX scores 10 today, which Breakaway calls Average. It is #18 of 90 in Pharma by Quality Score, with 4 of 14 chart checks firing. Up 22% on Nov 2, and still 23% over its Oct 30 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is IDXX's Quality Score?

IDXX scores 10 today, which Breakaway calls Average (6 to 10). That is #18 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind IDXX's 10.

Are insiders buying IDXX?

5 insiders sold $28.6M across 22 filings in the last 6 months. No open-⁠market buys on record. The newest is Sharon E. Underberg, EVP, GC & Corporate Secretary, who sold $4.4M on Nov 4. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.